The survival rates of patients who were both high expression of IGFIR/VEGF and IGFIR/VEGF-C also were significantly lower compared with patients who were negative or one of high expression of these molecules (P < 0.001).
Patients who were both high expression of IGFIR/VEGF and IGFIR/VEGF-C had unfavorable prognoses, and patients who were negative or one of high expression of these molecules had more favorable prognoses.
For both high expression of apoptotic caspase-3 (P=0.02, HR 1.6, 95% CI: 1.1 2.4) and high expression of proliferative Ki67 (P=0.03, HR 1.33, 95% CI: 1.02 1.74) a significantly worse association was found with RFP in IDC, but not in ILC (Table 2).
Both high expression of the VEGF-C and COX-2 were correlated with the presence of lymph node metastasis (P = 0.010, P = 0.012 respectively, both Chi-Square test) and LVI (P = 0.031, P = 0.016 respectively, both Chi-Square test).
The R value was defined as the Pearson's correlation between the HIS pattern (using "1" and "-1" for up- and downregulation, respectively) and the primary tumor's expression values, resulting in high R values for the tumors that tend to have both high expression of the upregulated genes and low expression of the downregulated genes in the human invasion signature.
In addition, the expression levels of AQP3 and AQP5 in 130 HCC cases were summarized in Table 2. Based on the scoring system used in the present study, 52 (40.00%) cases were both high expression of AQP3 and AQP5, 27 (20.77%) cases were both low expression of AQP3 and AQP5, 30 (23.08%) cases were AQP3 high and AQP5 low expression, and 21 (16.15%) cases were AQP3 low and AQP5 high expression.
Ward's retinoblastoma clusters 1 and 2 both displayed high expressions of cell cycle makers, but only Ward's retinoblastoma cluster 2 showed high gene expression of cone photoreceptor markers (Fig. S5D).
Those microarray chips containing "biofilms" in their experimental descriptions frequently show high expressions of both uspE and gadX as demonstrated in Figure 3.
In addition, the concomitant high expressions of both molecules were more predictive of lymph node involvement as compared with that of a single marker high expression or both low expressions.
Future experiments to test the physiological effects of LPA generated by GPAT will require the use of mammalian cells that have both a high expression of PPARγ and a low activity of GPAT that can be enhanced by transfection.
